Pi Legal Consultancy

  As we enter 2026, the global legal landscape is shifting rapidly. For international investors and businesses operating in the region, having a strategic partner is no longer a luxury—it is a necessity. At Pi Legal Consultancy , we are proud to start the new year with significant international recognition and a renewed commitment to legal excellence. Our January 2026 Bulletin is now released, highlighting our firm's recent achievements and providing critical regulatory updates for the Turkish market. A Year Defined by Global Recognition 2025 was a milestone year for our team. We are honored to announce that Pi Legal Consultancy has been recognized by multiple prestigious organizations for our client-focused approach and strategic capabilities: International Law Firm of the Year: Awarded by the London-based Prestige Awards Group . Banking and Finance Law Experts of the Year 2025: Granted by Global Law Experts, acknowledging our strategic achievements in the financial sector . Fi...

  The Regulation on Products Derived from Human Tissues and Cells and Centers Concerning These Products , published in the Official Gazette dated 4 September 2025 (No. 33007) , marks a major regulatory shift in Türkiye’s healthcare and biotechnology compliance framework. This new regulation introduces comprehensive quality, safety, licensing, authorization, inspection, and data governance standards for tissue and cell centers, biobanks, and human application facilities. It also repeals previous fragmented legislation and establishes a unified regulatory regime governing the production, storage, distribution, export, and clinical use of human-origin biological products. In this article, we provide a structured legal analysis of the Regulation, explain the roles of competent authorities, outline the key compliance obligations for healthcare operators, and assess the operational and investment implications for institutions operating in the life sciences and medical sectors. For the w...